PEPTONIC medical AB (XSAT:PMED) ROC %: -31.44% (As of Mar. 2026)

What is PEPTONIC medical AB ROC %?

PEPTONIC medical AB XSAT:PMED -25.00% ROC % is -31.44% as of Mar. 2026. The stock has 6 warning signs investors should review.

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. PEPTONIC medical AB's annualized return on capital (ROC %) for the quarter that ended in Mar. 2026 was -31.44%.

As of today (2026-06-28), PEPTONIC medical AB's WACC % is 8.08%. PEPTONIC medical AB's ROC % is -23.89% (calculated using TTM income statement data). PEPTONIC medical AB earns returns that do not match up to its cost of capital. It will destroy value as it grows.

PEPTONIC medical AB (XSAT:PMED) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, PEPTONIC medical AB's WACC % is 8.08%. PEPTONIC medical AB's ROC % is -23.89% (calculated using TTM income statement data). PEPTONIC medical AB earns returns that do not match up to its cost of capital. It will destroy value as it grows.

Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

PEPTONIC medical AB ROC % Related Terms

PEPTONIC medical AB ROC % Historical Data

* Premium members only.

The historical data trend for PEPTONIC medical AB's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PEPTONIC medical AB ROC % Chart

PEPTONIC medical AB Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

ROC %

Get a 7-Day Free Trial

-85.04

-40.36

-47.01

-48.68

-25.56

PEPTONIC medical AB Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
ROC %	Get a 7-Day Free Trial															-39.30	-18.72	-50.09	5.21	-31.44

PEPTONIC medical AB ROC % Calculation

PEPTONIC medical AB's annualized Return on Capital (ROC %) for the fiscal year that ended in Dec. 2025 is calculated as:

	ROC % (A: Dec. 2025 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (A: Dec. 2024 )	+	Invested Capital (A: Dec. 2025 ))	/ count )
=	-19.449 * ( 1 - 0% )	/	( (76.627	+	75.58)	/ 2 )
=	-19.449	/	76.1035
=	-25.56 %

where

	Invested Capital		(A: Dec. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	70.56	-	3.351	-	( 3.74	-	max(0, 22.008	-	12.59	+	3.74	))
=	76.627

	Invested Capital		(A: Dec. 2025 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	65.915	-	4.362	-	( 0.195	-	max(0, 27.67	-	13.643	+	0.195	))
=	75.58

PEPTONIC medical AB's annualized Return on Capital (ROC %) for the quarter that ended in Mar. 2026 is calculated as:

	ROC % (Q: Mar. 2026 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2025 )	+	Invested Capital (Q: Mar. 2026 ))	/ count )
=	-21.32 * ( 1 - 0% )	/	( (75.58	+	60.063)	/ 2 )
=	-21.32	/	67.8215
=	-31.44 %

where

	Invested Capital		(Q: Dec. 2025 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	65.915	-	4.362	-	( 0.195	-	max(0, 27.67	-	13.643	+	0.195	))
=	75.58

	Invested Capital		(Q: Mar. 2026 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	60.764	-	2.439	-	( 0.628	-	max(0, 11.589	-	9.851	+	0.628	))
=	60.063

Note: The Operating Income data used here is four times the quarterly (Mar. 2026) data. The tax rate is limited to between 0% and 100%.

Frequently Asked Questions Learn more about ROC % →

What does a ROC % of -31.44% mean?

PEPTONIC medical AB (XSAT:PMED) has a ROC % of -31.44% as of Mar. 2026. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on PEPTONIC medical AB and its competitors.

Is PEPTONIC medical AB's ROC % too high?

PEPTONIC medical AB's current ROC % is -31.44%.

How does PEPTONIC medical AB's ROC % compare to ZTS and UTHR?

PEPTONIC medical AB's ROC % of -31.44% can be compared against companies in the Drug Manufacturers industry. The industry median ROC % is 4.46. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROC % for a Drug Manufacturers company?

The median ROC % among Drug Manufacturers companies is 4.46, based on 982 companies in the industry. Companies in the top quartile (top 25%) have a ROC % significantly above this median, while those in the bottom quartile fall well below. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROC % mean?

A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on PEPTONIC medical AB and its competitors. For the Drug Manufacturers industry, the median ROC % is 4.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PEPTONIC medical AB's current ROC % is -31.44%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is PEPTONIC medical AB stock overvalued right now?

PEPTONIC medical AB (XSAT:PMED) has a current ROC % of -31.44%. The current ROC % is -31.44%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROC % calculated?

ROC % is calculated from a company's financial statements. For PEPTONIC medical AB (XSAT:PMED), the current ROC % is -31.44% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PEPTONIC medical AB Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies OSTO:ERMA OSTO:GABA OSTO:NEWBRY XSAT:ODI OSTO:VIVE XTER:MRK TSE:4502 XSWX:GALD SHSE:600276 NSE:SUNPHARMA XTAE:TEVA LSE:HLN XSWX:SDZ ZTS HKSE:03692 UTHR VTRS NSE:DIVISLAB OSTO:SOBI TSE:4507

Address Gustavslundsvagen 143, Bromma, SWE, SE-167 51

Website https://www.peptonicmedical.se

PEPTONIC medical AB is a pharmaceutical company. It is engaged in developing oxytocin-based products for the treatment of menopausal symptoms, such as vaginal atrophy and vaginal dryness. Oxytocin is for medical use and offers an alternative to estrogen and estrogen-like acting compounds for menopausal and postmenopausal women. The company is based in Sweden.